Exodus Point Capital Management, LP Apellis Pharmaceuticals, Inc. Call Options Transaction History
Exodus Point Capital Management, LP
- $10.1 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding APLS
# of Institutions
284Shares Held
125MCall Options Held
921KPut Options Held
761K-
Wellington Management Group LLP Boston, MA12.3MShares$298 Million0.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.2MShares$296 Million4.32% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$288 Million20.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$245 Million0.0% of portfolio
-
Morgan Stanley New York, NY9.63MShares$233 Million0.02% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.66B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...